µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© 8D1+["&
bbAJ5EqL
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© m8C
scCZ}
1¡¢Co-stimulators (or co-stimulating molecules) 'c&S%Ra[3G
2¡¢NK-kB .C?rToCY
3¡¢Immunoglobulin superfamily n|Smy\0
4¡¢antigen-presenting cell (APC) R4q)FXW29
5¡¢death domain o.M.zkP a
6¡¢CCR and CXCR ;+Uc}=
7¡¢Lectin (or mitogen) &I=F4 z
8¡¢Clusters of differentiation, CD) <[w>Mbqj_
9¡¢B7 family [r;hF
10¡¢Cytotoxic T lymphocyte, CTL) &<\
i37y
11¡¢IL-15 and IL-15 receptor (IL-15R) X4dXO5\
12¡¢MHC restriction KQv97#n1
13¡¢Affinity-chromatography ITf,
)?|]Y
14¡¢Cyctosprin A, CsA />[X
k
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) t,>j{SK ~
3,4m|Z2)
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© _|qs-USA
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 >UDb:N[
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ >wJt# ZB
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ .Bb86Y=3
,[t>N>10TH
Èý¡¢ÎÊ´ðÌ⣨25·Ö£©
Rd^X.
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ 9Vh> ty1|_
ѪҺ²¡Ñ§×¨Òµ£º DS]C`aM9
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿